Beijing Tiantan Biological Products Co., Ltd. (SHA:600161)
China · Delayed Price · Currency is CNY 14.75
-0.03 (-0.20%)
Apr 14, 2026, 3:00 PM CST
SHA:600161 Market Cap
SHA:600161 has a market cap or net worth of 29.17 billion as of April 14, 2026. Its market cap has decreased by -27.27% in one year.
Market Cap
29.17B
Enterprise Value
30.92B
Revenue
6.17B
Ranking
n/a
PE Ratio
26.82
Stock Price
14.75
Market Cap Chart
Since March 8, 2000, SHA:600161's market cap has increased from 3.95B to 29.17B, an increase of 638.85%. That is a compound annual growth rate of 7.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 14, 2026 | 29.17B | -9.73% |
| Dec 31, 2025 | 32.31B | -20.29% |
| Dec 31, 2024 | 40.54B | -20.49% |
| Dec 29, 2023 | 50.98B | 30.38% |
| Dec 30, 2022 | 39.10B | -1.67% |
| Dec 31, 2021 | 39.77B | -23.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Allist Pharmaceuticals | 43.19B |
| Asymchem Laboratories (Tianjin) | 42.57B |
| Hebei Changshan Biochemical Pharmaceutical | 40.78B |
| Shanghai RAAS Blood Products | 37.64B |
| Chongqing Zhifei Biological Products | 37.06B |
| Hualan Biological Engineering | 27.25B |
| Xiamen Amoytop Biotech | 25.92B |
| Suzhou Zelgen Biopharmaceuticals | 25.88B |